Open Government Canada
Guidance document - Nonprescription topical nasal decongestants labelling standard
Published by Health Canada | Santé Canada
About this dataset
This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.